Boston Scientific (BSX) Tops Q4 EPS by 10c; Guides Q1, FY11

February 1, 2011 5:03 PM

Boston Scientific Corporation (NYSE: BSX) reported Q4 EPS of $0.20, $0.10 better than the analyst estimate of $0.10. Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found